Giuseppe Morgante

ORCID: 0000-0001-5024-2321 · 19 papers in corpus
lab-animal 2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01344-9

BACKGROUND: Endocrine-disrupting chemicals (EDCs) interfere with the endocrine system and negatively impact reproductive health. Biochanin A (BCA), an isoflavone with anti-inflammatory and estrogen-like properties, has been identified as on…

guideline 2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01372-5

The polycystic ovary syndrome (PCOS) is a multifaced disease of the reproductive age associated with several comorbidities including infertility. Very few documents regarding the management of the infertility in women with PCOS, including g…

other 2025
JMIR research protocols ·doi:10.2196/63683

BACKGROUND: Norgestimate (NGM) is a progestin with negligible androgenic activity that is available in combination with ethinyl estradiol (EE) as a monophasic combined oral contraceptive (COC). It has been more than 30 years since a clinica…

rct 2020
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2020.1736546

Objectives: The aim of the study was to update the results of a previous study published 10 years ago and compare the effect on hyperandrogenism of a newer progestin, dienogest (DNG), in a combined oral contraceptive (COC) formulation with …

lab-animal 2020
Cells ·doi:10.3390/cells9051121

Embryo implantation has been defined as the "black box" of human reproduction. Most of the knowledge on mechanisms underlining this process derives from animal models, but they cannot always be translated to humans. Therefore, the developme…

rct 2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00611-1

BACKGROUND: The presence of submucous fibroids strongly impacts on IVF results, therefore, these patients should be considered for surgical or medical treatment. The aim of this study was to assess the role of Ulipristal acetate (UPA), a se…

observational 2018
Journal of psychosomatic obstetrics and gynaecology ·doi:10.1080/0167482X.2017.1386171

INTRODUCTION: Endometriosis is a gynecological disease with a severe impact on quality of life. The aim of this study is to assess mental health status in a group of women with endometriosis, investigating their clinical history, pain sympt…

review 2018
Minerva ginecologica ·doi:10.23736/s0026-4784.17.04172-7

Vitamin D or calcitriol, which was first identified back in 1920, has a key role in bone metabolism and mineralization, and in calcium and magnesium homeostasis. A nuclear receptor (VDR) mediates vitamin D actions in a lot of organs like bo…

nonrandomized-trial 2016
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-016-0184-7

BACKGROUND: The status characterized by the imbalance between pro-oxidants and antioxidants molecules, defined as oxidative stress, has been suggested to be involved in the pathogenesis of subfertility in females. This study aims to evaluat…

review 2016
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-016-0173-x

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 5-10 % of women of reproductive age. It generally manifests with oligo/anovulatory cycles, hirsutism and polycystic ovaries, together with a considerable prevalence …

review 2016
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2016.05.032

Endometriotic lesions are associated with hormonal imbalance, including increased estrogen synthesis, metabolism and progesterone resistance. These hormonal changes cause increased proliferation, inflammation, pain and infertility. Hormonal…

nonrandomized-trial 2013
Contraception ·doi:10.1016/j.contraception.2012.09.003

BACKGROUND: Insulin resistance may be induced by both the estrogen and progestin component in hormonal contraception. When estrogen dose is reduced from 50 to 20 mcg, the extent of hyperinsulinemia decreases. Recently, the oral combination …

other 2003
Fertility and sterility ·doi:10.1016/s0015-0282(03)00070-0
review 2002
Drug safety ·doi:10.2165/00002018-200225110-00002

The growth of a uterine leiomyoma growth stops and regresses after the menopause suggesting that leiomyoma growth is dependent on ovarian steroids. Therefore, estrogen has received much attention as the major factor responsible for the deve…

rct 1999
Human Reproduction ·doi:10.1093/humrep/14.9.2371

The most effective therapy for endometriosis is a matter for debate. The aim of the present randomized study was to evaluate the efficacy of low doses of danazol on recurrence of pelvic pain in patients with moderate or severe endometriosis…

nonrandomized-trial 1999
Gynecologic and obstetric investigation ·doi:10.1159/000010118

The aim of this study was to evaluate the effects of danazol in reducing the volume of fibromyomas and in the treatment of associated symptoms. Twenty women (34-42 years) with uterine fibromyomas were treated with 400 mg/day of danazol for …

1998
nonrandomized-trial 1997
Human Reproduction ·doi:10.1093/humrep/12.2.357

We report the results of administration of danazol after suspension of gonadotrophin-releasing hormone analogue (GnRHa) therapy for uterine myomas. A total of 21 women with uterine myomas was treated with 100 mg danazol for 6 months after G…

review 1996
Minerva ginecologica

Uterine fibromyomatosis is a widely recognised and well studied pathology that is found in around 30% of over 35-year-old women. It has been extensively demonstrated that the etiology of fibromyomas is hormone dependent and to date the main…